Advisors Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42M Buy
349,476
+6,787
+2% +$784K 0.7% 11
2025
Q4
$36.1M Buy
342,689
+2,380
+0.7% +$223K 0.61% 16
2025
Q3
$28.6M Buy
340,309
+43,520
+15% +$3.58M 0.48% 25
2025
Q2
$23.5M Buy
296,789
+9,009
+3% +$716K 0.42% 31
2025
Q1
$25.8M Buy
287,780
+31,065
+12% +$2.9M 0.49% 29
2024
Q4
$25.5M Sell
256,715
-11,861
-4% -$1.22M 0.47% 28
2024
Q3
$30.5M Sell
268,576
-2,147
-0.8% -$255K 0.56% 22
2024
Q2
$33.5M Sell
270,723
-37,594
-12% -$4.84M 0.65% 17
2024
Q1
$40.7M Sell
308,317
-28,562
-8% -$3.52M 0.78% 12
2023
Q4
$36.7M Sell
336,879
-80,867
-19% -$8.39M 0.75% 15
2023
Q3
$43M Sell
417,746
-29,978
-7% -$3.23M 0.93% 11
2023
Q2
$51.7M Sell
447,724
-84,956
-16% -$9.65M 1.06% 8
2023
Q1
$56.7M Sell
532,680
-73,126
-12% -$7.9M 1.15% 7
2022
Q4
$67.2M Sell
605,806
-68,669
-10% -$7.02M 1.38% 5
2022
Q3
$58.1M Sell
674,475
-54,663
-7% -$4.88M 1.22% 6
2022
Q2
$66.5M Sell
729,138
-32,585
-4% -$2.89M 1.26% 8
2022
Q1
$62.5M Buy
761,723
+34,602
+5% +$2.73M 0.96% 10
2021
Q4
$55.7M Buy
727,121
+61,521
+9% +$4.9M 0.8% 13
2021
Q3
$50M Buy
665,600
+89,803
+16% +$6.83M 0.76% 14
2021
Q2
$44.8M Buy
575,797
+163,312
+40% +$12.1M 0.66% 20
2021
Q1
$30.3M Buy
412,485
+105,248
+34% +$7.76M 0.47% 28
2020
Q4
$24M Buy
307,237
+112,898
+58% +$8.63M 0.4% 41
2020
Q3
$15.4M Buy
194,339
+39,177
+25% +$3.07M 0.28% 58
2020
Q2
$11.4M Sell
155,162
-9,991
-6% -$752K 0.22% 88
2020
Q1
$12.1M Sell
165,153
-79,638
-33% -$6.26M 0.29% 70
2019
Q4
$21.2M Sell
244,791
-48,510
-17% -$3.98M 0.37% 50
2019
Q3
$23.6M Sell
293,301
-137,596
-32% -$11M 0.43% 36
2019
Q2
$34.5M Sell
430,897
-133,749
-24% -$10.2M 0.62% 20
2019
Q1
$44.8M Sell
564,646
-112,572
-17% -$8.42M 0.8% 12
2018
Q4
$49.4M Sell
677,218
-4,934
-0.7% -$348K 0.99% 9
2018
Q3
$46.2M Sell
682,152
-550
-0.1% -$35K 0.75% 12
2018
Q2
$39.5M Buy
682,702
+48,170
+8% +$2.72M 0.67% 13
2018
Q1
$32.8M Buy
634,532
+31,493
+5% +$1.7M 0.55% 21
2017
Q4
$32.4M Buy
603,039
+15,024
+3% +$833K 0.53% 21
2017
Q3
$35.9M Sell
588,015
-118,735
-17% -$7.2M 0.6% 15
2017
Q2
$43.2M Sell
706,750
-70,645
-9% -$4.3M 0.72% 8
2017
Q1
$47.1M Sell
777,395
-65,160
-8% -$3.95M 0.79% 7
2016
Q4
$47.3M Sell
842,555
-25,086
-3% -$1.47M 0.79% 5
2016
Q3
$51.7M Buy
867,641
+1,013
+0.1% +$59.2K 0.85% 4
2016
Q2
$47.6M Sell
866,628
-36,097
-4% -$1.92M 0.77% 4
2016
Q1
$45.6M Sell
902,725
-42,024
-4% -$2.06M 0.76% 4
2015
Q4
$47.6M Buy
944,749
+59,505
+7% +$3M 0.76% 4
2015
Q3
$41.7M Sell
885,244
-143,408
-14% -$7.62M 0.67% 10
2015
Q2
$55.9M Sell
1,028,652
-108,645
-10% -$6.09M 0.77% 5
2015
Q1
$62.4M Sell
1,137,297
-64,516
-5% -$3.65M 0.83% 5
2014
Q4
$65.1M Sell
1,201,813
-121,726
-9% -$6.78M 0.87% 6
2014
Q3
$74.9M Sell
1,323,539
-105,786
-7% -$5.94M 1.03% 2
2014
Q2
$78.9M Sell
1,429,325
-28,686
-2% -$1.56M 1.09% 2
2014
Q1
$79M Buy
1,458,011
+29,529
+2% +$1.53M 1.2% 1
2013
Q4
$68.2M Buy
1,428,482
+18,570
+1% +$849K 1.1% 1
2013
Q3
$64.1M Buy
1,409,912
+64,151
+5% +$2.93M 1.14% 1
2013
Q2
$59.6M Buy
+1,345,761
New +$60.1M 1.13% 2

Other funds holding MRK

Advisors Asset Management's MRK Position: Q1 2026 in Review

Advisors Asset Management increased its Merck (MRK) stake by 2% in Q1 2026, buying an estimated $784K and bringing the position to 349,476 shares worth $42M. The position accounts for 0.7% of the portfolio, ranked #11.

Advisors Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $79M in Q1 2014. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Advisors Asset Management held 349,476 shares of Merck worth $42M as of Q1 2026.
  • Advisors Asset Management bought 6,787 Merck shares in Q1 2026, an estimated $784K.
  • Merck made up 0.7% of Advisors Asset Management's portfolio in Q1 2026, its #11 holding.
  • Advisors Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Advisors Asset Management's Merck position peaked at $79M in Q1 2014.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.